Caribou Biosciences, Inc.
Caribou Biosciences, Inc. (CRBU) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
crbu · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$7.00
Consensus
$5.00
+171.7% upside
Low
$3.00
Median: $5 · Last Close: $1.84
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.00
171.7% upside
High Target
$7
280.4%
Low Target
$3
63.0%
Current Price
$1.84
as of today
Based on analyst price targets, the CRBU stock price prediction for the next 12 months ranges from $3 to $7. The consensus CRBU price forecast of $5.00 implies 171.7% upside from the current price of $1.84.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.80 | ↓ 2.32% |
1-day model range: $1.76–$1.83. Peak: $1.83 (-2.32%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CRBU · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-09 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-03 | Citigroup | Maintains | Buy→Buy |
| 2025-04-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-07 | B of A Securities | Maintains | Buy→Buy |
| 2024-11-26 | Citigroup | Maintains | Buy→Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Caribou Biosciences, Inc. (CRBU) stock. Of the recent 40 rating actions, 1 were upgrades and 0 were downgrades. 9 analysts currently cover CRBU.
Analyst Recommendation Trends
CRBU analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$24M
↓ 22.5% YoY
Revenue Next Year
$27M
↑ 14.6% YoY
EPS This Year
$-1.16
EPS Next Year
$-1.28
↑ 11.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRBU EPS of $-1.16 for the current fiscal year, based on estimates from 3 analysts. The CRBU revenue forecast is $24M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CRBU stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CRBU price target is $5.00 (+171.7% upside), with an analyst consensus of Buy.
The CRBU short-term stock prediction for tomorrow is $1.80 (-2.32%). The CRBU stock prediction for 2030 projects a range of $1–$1.
Caribou Biosciences, Inc. trades on NASDAQ under the ticker CRBU. The CRBU stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CRBU forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month CRBU price target is $5.00, with a high forecast of $7.00 and a low of $3.00. The median price target is shown in the chart above when available. This implies +171.7% potential upside from the current price of $1.84.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.